Bookmark and Share

BioActivity Data for Compound tartaric acid (CID 875)

BioActivity Outcomes:
Inactive(93)
 
 
Inconclusive(2)
 
 
Unspecified(8)
 
 
Top Targets:
NR LBD PPAR(8)
 
 
 
NR LBD AR(7)
 
 
NR LBD ER(7)
 
 
NR LBD Fxr(4)
 
 
NR LBD GR(4)
 
 
BioAssay Types:
Confirmatory(63)
 
 
 
Summary(24)
 
 
Literature(8)
 
 
BioAssay Categories:
In vitro(2)
 
 
In vivo(1)
 
 
Biochemical(1)
 
 
Toxicity(6)
 
 
ADME(3)
 
 
Cell-based(4)
 
 
BioActivity Types:
Potency(80)
 
 
 
IC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 103    Data Row: 103   Total Pages: 6   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103349923]
IC50 25Inhibition of 50% of the integrase-mediated catalysis of the V1/V2 substrate [AID226214, Type: Literature]
View
2
[SID103349923]
IC50 25Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate [AID226216, Type: Literature]
View
3
[SID103349923]
Therapeutic index (ratio of CT5 to ED50). [AID235210, Type: Literature]
View
4
[SID103349923]
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM [AID977602, Type: Literature]
View
5
[SID103349923]
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM [AID977599, Type: Literature]
View
6
[SID103349923]
Inhibition of Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration reaction at a concentration of 25 uM [AID91578, Type: Literature] [gi:82312013]
View
7
[SID103349923]
Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5% [AID104233, Type: Literature]
View
8
[SID103349923]
Inhibition of MT-2 cell growth by 5% or less over a 72 hr time period. [AID106733, Type: Literature]
View
9
[SID144212369]
Potency-Replicate_1 qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability [AID720634, Type: confirmatory]
View
10
[SID144212369]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen [AID743194, Type: confirmatory]
View
11
[SID144212369]
Potency-Replicate_1 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability [AID651634, Type: confirmatory]
View
12
[SID144212369]
Potency-Replicate_1 qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability [AID651633, Type: confirmatory]
View
13
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other]
View
14
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other]
View
15
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other]
View
16
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other]
View
17
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other]
View
18
[SID109777]
NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other]
View
19
[SID109777]
NCI AIDS Antiviral Assay [AID179, Type: confirmatory]
View
20
[SID430469]
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other]
View